BRCA2 and triple-negative breast carcinoma: These findings are consistent with data reported by others showing that triple negative breast cancers had the highest prevalence of deleterious gene mutations among the four molecular breast cancer subgroups (4), and that mutation rates of BRCA1 and BRCA2 were higher in TNBC compared to other breast cancer subtypes (10).